These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 14711144)

  • 1. Effect of PTU on IL-12 and IL-10 in psoriasis.
    Elias AN; Nanda VS; Barr RJ
    J Drugs Dermatol; 2003 Dec; 2(6):645-8. PubMed ID: 14711144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD1a expression in psoriatic skin following treatment with propylthiouracil, an antithyroid thioureylene.
    Elias AN; Nanda VS; Barr RJ
    BMC Dermatol; 2003 Jul; 3():3. PubMed ID: 12841851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p16 expression in psoriatic lesions following therapy with propylthiouracil, an antithyroid thioureylene.
    Elias AN; Barr RJ; Nanda VS
    Int J Dermatol; 2004 Dec; 43(12):889-92. PubMed ID: 15569009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of single daily dose of methimazole and propylthiouracil in the treatment of Graves' hyperthyroidism.
    He CT; Hsieh AT; Pei D; Hung YJ; Wu LY; Yang TC; Lian WC; Huang WS; Kuo SW
    Clin Endocrinol (Oxf); 2004 Jun; 60(6):676-81. PubMed ID: 15163329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral propylthiouracil for the treatment of resistant plaque psoriasis.
    Chowdhury MM; Marks R
    J Dermatolog Treat; 2001 Jun; 12(2):81-5. PubMed ID: 12243663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic efficacy and safety of propylthiouracil in psoriasis: an open-label study.
    Gnanaraj P; Malligarjunan H; Dayalan H; Karthikeyan S; Narasimhan M
    Indian J Dermatol Venereol Leprol; 2011; 77(6):673-6. PubMed ID: 22016273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of combination therapy with propylthiouracil and cholestyramine in the treatment of Graves' hyperthyroidism.
    Tsai WC; Pei D; Wang TF; Wu DA; Li JC; Wei CL; Lee CH; Chen SP; Kuo SW
    Clin Endocrinol (Oxf); 2005 May; 62(5):521-4. PubMed ID: 15853819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical efficacy of propylthiouracil and its influence on prolactin in psoriatic patients.
    Malligarjunan H; Gnanaraj P; Subramanian S; Elango T; Dayalan H
    Clin Biochem; 2011 Oct; 44(14-15):1209-13. PubMed ID: 21820424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-thyroid thioureylenes in the treatment of psoriasis.
    Elias AN
    Med Hypotheses; 2004; 62(3):431-7. PubMed ID: 14975517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum TNF-alpha in psoriasis after treatment with propylthiouracil, an antithyroid thioureylene.
    Elias AN; Nanda VS; Pandian R
    BMC Dermatol; 2004 Apr; 4():4. PubMed ID: 15119959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of hyperthyroidism and propylthiouracil treatment on liver biochemical tests.
    Aydemir S; Bayraktaroglu T; Demircan N; Sert M; Açikgoz S; Tekin IO; Ustundag Y
    Int J Clin Pract; 2005 Nov; 59(11):1304-8. PubMed ID: 16236085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum levels of the pro-inflammatory cytokine interleukin-12 and the anti-inflammatory cytokine interleukin-10 in patients with psoriasis treated by the Goeckerman regimen.
    Borska L; Andrys C; Krejsek J; Hamakova K; Kremlacek J; Ettler K; Fiala Z
    Int J Dermatol; 2008 Aug; 47(8):800-5. PubMed ID: 18717859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of propylthiouracil and methimazole on serum levels of interleukin-2 receptors in patients with psoriasis.
    Elias AN; Goodman MM; Rohan MK
    Int J Dermatol; 1993 Jul; 32(7):537-40. PubMed ID: 8340196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antioxidant potential of propylthiouracil in patients with psoriasis.
    Utaş S; Köse K; Yazici C; Akdaş A; Keleştimur F
    Clin Biochem; 2002 May; 35(3):241-6. PubMed ID: 12074833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Downregulation of involucrin in psoriatic lesions following therapy with propylthiouracil, an anti-thyroid thioureylene: immunohistochemistry and gene expression analysis.
    Gnanaraj P; Dayalan H; Elango T; Malligarjunan H; Raghavan V; Rao R
    Int J Dermatol; 2015 Mar; 54(3):302-6. PubMed ID: 25267471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment outcome of Graves' disease in Thai children.
    Somnuke PH; Pusuwan P; Likitmaskul S; Santiprabhob J; Sawathiparnich P
    J Med Assoc Thai; 2007 Sep; 90(9):1815-20. PubMed ID: 17957924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A pilot study of pharmacokinetically guided dosing of oral methotrexate in the initial phase of psoriasis treatment.
    Hroch M; Chladek J; Simkova M; Vaneckova J; Grim J; Martinkova J
    J Eur Acad Dermatol Venereol; 2008 Jan; 22(1):19-24. PubMed ID: 18031504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simultaneous measurement of multiple Th1 and Th2 serum cytokines in psoriasis and correlation with disease severity.
    Jacob SE; Nassiri M; Kerdel FA; Vincek V
    Mediators Inflamm; 2003 Oct; 12(5):309-13. PubMed ID: 14760939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced apoptosis in psoriatic plaques after treatment with propylthiouracil.
    Elias AN; Barr RJ
    Eur J Dermatol; 2007; 17(4):353-4. PubMed ID: 17540660
    [No Abstract]   [Full Text] [Related]  

  • 20. A controlled trial of topical propylthiouracil in the treatment of patients with psoriasis.
    Elias AN; Dangaran K; Barr RJ; Rohan MK; Goodman MM
    J Am Acad Dermatol; 1994 Sep; 31(3 Pt 1):455-8. PubMed ID: 8077472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.